Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: A PET/microdialysis study

Citation
Wk. Schiffer et al., Stereoselective inhibition of dopaminergic activity by gamma vinyl-GABA following a nicotine or cocaine challenge: A PET/microdialysis study, LIFE SCI, 66(13), 2000, pp. PL169-PL173
Citations number
11
Categorie Soggetti
Biochemistry & Biophysics
Journal title
LIFE SCIENCES
ISSN journal
00243205 → ACNP
Volume
66
Issue
13
Year of publication
2000
Pages
PL169 - PL173
Database
ISI
SICI code
0024-3205(20000218)66:13<PL169:SIODAB>2.0.ZU;2-B
Abstract
Elevation of endogenous GABA by the racemic mixture of gamma vinyl-GABA (GV G, Vigabatrin(R)) decreases extracellular nucleus accumbens (NAc) dopamine (DA) levels and diminishes the response to many drugs of abuse known to ele vate DA in the mesocorticolimbic system. We investigated the effects of the individual enantiomers (S(+)GVG, R(-)-GVG) on cocaine-induced NAc DA in ro dents as well as the effects of nicotine-induced increases in primates. In a series of microdialysis experiments in freely moving animals, S(+)-GVG (1 50 mg/kg), R(-)-GVG (150 mg/kg) or racemic (R, S) GVG (300 mg/kg) was admin istered 2.5 hours prior to cocaine (20 mg/kg) administration. When compared with cocaine alone, the R(-) enantiomer did not significantly inhibit coca ine induced NAc DA release. S(+)-GVG, at half the dose of the racemic mixtu re (150 mg/kg), inhibited cocaine-induced DA elevation by 40%, while the ra cemic mixture (300 mg/kg) inhibited cocaine-induced DA release by 31.%. In addition, our PET studies in primates demonstrated that S(+)GVG completely inhibits nicotine-induced increases in the corpus striatum, again at half t he dose of the racemic mixture. The R(-) enantiomer was ineffective. Althou gh the S(+) enantiomer has been well established as the active compound in the treatment of epilepsy, the efficacy of this enantiomer with regard to m esolimbic DA inhibition generates a complex series of clinical and neuroche mical issues. Further investigations will determine the locus of action and physiologic properties of each enantiomer. (C) 2000 Elsevier Science Inc.